Evidence map›Paper›PMID 26822727›Full record

ArticleAJNR. American journal of neuroradiology2016

Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease).

J P Dyke, D Sondhi, H U Voss, K Yohay, C Hollmann, D Mancenido, S M Kaminsky, L A Heier, K D Rudser, B Kosofsky and 3 more

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.AJNR. American journal of neuroradiology · 2020
    Article
  12. Article
  13. Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy.Therapeutics and clinical risk management · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

J P DykeFrom the Departments of Radiology (J.P.D., H.U.V., L.A.H., D.B.) jpd2001@med.cornell.edu.ORCID 0000-0001-7170-488X
D SondhiGenetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.).ORCID 0000-0002-2218-5910
H U VossFrom the Departments of Radiology (J.P.D., H.U.V., L.A.H., D.B.).ORCID 0000-0003-2811-2074
K YohayPediatrics (K.Y., B.K.).ORCID 0000-0001-5560-3392
C HollmannGenetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.).ORCID 0000-0001-7392-5758
D MancenidoGenetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.).ORCID 0000-0001-8920-1631
S M KaminskyGenetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.).ORCID 0000-0003-1869-834X
L A HeierFrom the Departments of Radiology (J.P.D., H.U.V., L.A.H., D.B.).ORCID 0000-0001-5519-9326
K D RudserDivision of Biostatistics (K.D.R.), Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0001-9968-0090
B KosofskyPediatrics (K.Y., B.K.).ORCID 0000-0001-6360-343X
B J CaseyPsychiatry (B.J.C.), Weill Cornell Medical College, New York, New York.ORCID 0000-0003-2905-9834
R G CrystalGenetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.).ORCID 0000-0001-6177-6839
D BallonFrom the Departments of Radiology (J.P.D., H.U.V., L.A.H., D.B.) Genetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.).ORCID 0000-0002-7162-9020
Genetic Technologies (Australia) · AUDSM (Netherlands) · NLCornell University · USKinan Hospital · JPUniversity of Minnesota · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Training & EducationU54NS065768 · NINDS · UNIVERSITY OF MINNESOTA · PI WHITLEY, CHESTER B. · 2009 to 2024
$17.7M
Creating a Pediatric Imaging-Genomics Data ResourceRC2DA029475 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, LINDA, DALE, ANDERS M · 2009 to 2011
$9.1M
Gene Therapy for Batten Disease Using AAVrh.10 Expressing Human CLN2 cDNAR01NS061848 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI CRYSTAL, RONALD G · 2010 to 2013
$3.7M
NCATS NIH HHS UL1 TR000114NCATS NIH HHS UL1 TR002384NIDA NIH HHS RC2 DA029475NINDS NIH HHS R01 NS061848NINDS NIH HHS U54 NS065768
6 · The paper itself

Abstract

background and purposeLate infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND

methodsFifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness.

resultsAn increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres).

conclusionsThis study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.

Indexed as

BrainChildDisease ProgressionFemaleHumansMagnetic Resonance ImagingMaleNerve DegenerationNeuronal Ceroid-LipofuscinosesRetrospective StudiesTripeptidyl-Peptidase 1Tripeptidyl-Peptidase 1

Identifiers

PMID26822727
PMCPMC4907890
OpenAlexW2307888872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.